Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke A Phase 1/2a Study

Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in StrokeA Phase 1/2a Study Aha Journals   Source Aha Journals 2016;47:1817-1824. DOI: 10.1161/STROKEAHA.116.012995 Gary K. Steinberg, MD, PhD; Douglas Kondziolka, MD; Lawrence...

Permeating the Blood Brain Barrier and Abrogating the Inflammation in Stroke: Implications for Stroke Therapy

Permeating the Blood Brain Barrier and Abrogating the Inflammation in Stroke: Implications for Stroke Therapy Bentham Science Publishers   Source Current Pharmaceutical Design, 2012, 18, 3670-3676 Cesar V. Borlonganb,*, Loren E. Gloverb, P.R. Sanbergb and David...